SCHEMBL467904

SCHEMBL467904

CCOC(OCC)[SiH2]CNC1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
SHBG P04278 1/20 0.32
HTT P42858 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
THRB P10828 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ANPEP P15144 2/20 0.31
ERAP2 Q6P179 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31
SCN1A P35498 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28150416 0.98 KDM4E (0.36) KDM4EALDH1A1POLBSHBGHTT
SCHEMBL56308 0.81 KDM4E (0.39) KDM4EALDH1A1POLBHTTCYP1A2
SCHEMBL3700273 0.80 KDM4E (0.37) KDM4EALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL28719522 0.80 DPP7 (0.37) KDM4EALDH1A1POLB
SCHEMBL16197507 0.76 KDM4E (0.35) KDM4EALDH1A1POLBSHBGHTT
SCHEMBL17750056 0.76 CYP1A2 (0.34) SHBGCYP1A2
SCHEMBL22418680 0.75 ADH1B (0.33)
SCHEMBL15127343 0.72 KDM4E (0.36) KDM4EALDH1A1POLBHTTCYP1A2
SCHEMBL934315 0.72 KDM4E (0.50) KDM4EALDH1A1POLBSHBGHTT
SCHEMBL628667 0.71 KDM4E (0.32) KDM4EALDH1A1HTTMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 642 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026041693-A1 HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS SPSV B.V. (NL) 2026-02-26 WO claimed
EP-4700098-A1 HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS SPSV B.V. (NL) 2026-02-25 EP claimed
EP-3212292-B1 POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS OREAL (FR) 2021-01-20 EP claimed
EP-3081612-B1 PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES CEMEDINE CO LTD (JP) 2018-11-14 EP claimed
US-20170335066-A1 POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS L'OREAL (FR) 2017-11-23 US claimed
EP-3212292-A1 POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS L'OREAL (FR) 2017-09-06 EP claimed
WO-2016066610-A1 POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS L'OREAL (FR) 2016-05-06 WO claimed
WO-2016066613-A1 POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS L'OREAL (FR) 2016-05-06 WO claimed
US-8815985-B2 Curable composition KANEKA CORPORATION (JP) 2014-08-26 US claimed
CN-122029238-A Curable composition and cured product 株式会社钟化 2026-05-12 CN disclosed
EP-4727982-A1 PRIMER COMPOSITION, ADHESIVE SYSTEM, AND RELATED PROCESSES 3M Innovative Properties Company (US) 2026-04-22 EP disclosed
EP-3585851-B1 AIR AND WATER BARRIER ARTICLE INCLUDING INELASTIC POROUS LAYER 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-01 EP disclosed
US-12584022-B2 Solvochromic effect pigments, method of production and use thereof ECKART GMBH (DE) 2026-03-24 US disclosed
EP-4703405-A1 CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME Kaneka Corporation (JP) 2026-03-04 EP disclosed
CN-1861664-A Process for the production of dispersions of cross linked organopolysiloxanes WACKER CHEMIE AG (DE) 2006-11-15 CN disclosed
US-20060252903-A1 Curing composition KANEKA CORPORATION 2006-11-09 US disclosed
EP-1717240-A1 Organoalkoxysilanes for use in moisture curable compositions Sika Technology AG (CH) 2006-11-02 EP disclosed
CN-1784473-A Curable composition KANEGAFUCHI CHEMICAL IND (JP) 2006-06-07 CN disclosed
US-20060089432-A1 Curable composition KANEKA CORPORATION (JP) 2006-04-27 US disclosed
EP-1624027-A1 CURING COMPOSITION KANEKA CORPORATION (JP) 2006-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170335066-A1 POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS KRT18, DSG1, KRTCAP2 KDM4E 113/4885ALDH1A1 857/4885POLB 2104/4885
US-12584022-B2 Solvochromic effect pigments, method of production and use thereof PPOX, TDO2, SCO2 KDM4E 3573/4885ALDH1A1 2915/4885POLB 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.